Opinion
Video
Author(s):
An expert discusses how TAR-200 shows promise for non–muscle invasive bladder cancer (NMIBC) treatment, with medical professionals optimistic about its targeted delivery, potentially improved outcomes, and transformative approach to bladder cancer management.
Video content above is prompted by the following:
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.